arrow
A

Aravinda M. de Silva

University of North Carolina Chapel Hill
H指数:55
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiplex sample-sparing assay for detecting type-specific antibodies to Zika and dengue viruses: an assay development and validation study

多重样品节约型检测方法:用于检测寨卡病毒和登革热病毒型特异性抗体的方法开发与验证研究

2025-02-010
OAAI
Effect of single-dose, live, attenuated dengue vaccine in children with or without previous dengue on risk of subsequent, virologically confirmed dengue in Cebu, the Philippines: a longitudinal, prospective, population-based cohort study
2024-07-013
OAAI
Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes
2023-12-010
OAAI
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
MBIO
IF4.7
2022-10-267
OAAI
Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020
MSPHERE
IF3.1
2022-06-294
OAAI
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals (vol 6, e00275-21, 2021)
MSPHERE
IF3.1
2021-10-270
OAAI
Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies
2021-10-1520
OAAI
Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
MSPHERE
IF3.1
2021-08-2538
OAAI